IBiS reveals virus characteristics compatible with HIV treatment
The discovery was made possible by studying an exclusive group of people called the “elite HIV controllers,” who are able to control the virus without the need to take antiretroviral treatment.
The Institute of Biomedicine of Seville (IBiS), in collaboration with the Massachusetts General Hospital, Massachusetts Institute of Technology and Harvard in Boston, conducted a study that opens new possibilities for the treatment of infection caused by the human immunodeficiency virus (HIV). an exceptional group of people… + read more
Specific microRNA genetic signature identifying hepatitis C and HIV co-infection in liquid biopsy
A specific microRNA signature has been described that is present in extracellular vesicles of individuals coinfected with hepatitis C virus and human immunodeficiency, which differs from that of individuals monoinfected with HCV. + read more
Significant progress in combating latency, a major challenge in the fight against HIV
An international study coordinated by MELIS-UPF researchers Andreas Meierhans and Juana Diez has identified Schlafen 12, a new HIV limiting factor that could pave the way for new strategies to treat the infection. + read more
They identify a new factor that sheds light on the spread of HIV
When a new HIV infection occurs, contrary to popular belief, only one variant is transmitted – a process known as a “transmission bottleneck”, a phenomenon that has been studied for some time. + read more
Resistance to antiretroviral treatment in patients diagnosed with HIV
According to the Council in a press release, resistance transmitted to antiretroviral drugs has been low in recent years and remains stable. + read more
The HIV capsid acts as a molecular carrier and delivers material to its core.
The virus infects certain immune cells and steals their genetic program to multiply and replicate its own genetic material. + read more
Deaths from cervical cancer could be reduced by 63% thanks to WHO screening recommendations
HPV causes almost all types of cervical cancer, and in low- and middle-income countries there has been a shift from Pap tests to HPV screening. + read more